Carlyle Group in Advanced Discussions to Purchase Baxter's Kidney Care Division
Friday, 5 July 2024, 15:55
Carlyle in Negotiations to Acquire Baxter's Nephrology Unit
The Carlyle Group, a prominent private equity firm, is in advanced talks to purchase Baxter International's kidney care division, according to insider sources.
Significant Potential Impact
- If finalized, this deal could reshape the competitive landscape in the nephrology care market.
- Sources suggest that the negotiations are progressing well, indicating a potential major acquisition.
- This move could bolster Carlyle's presence in the healthcare investment sector and offer strategic growth opportunities.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.